Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations

por Riudavets, M., Sullivan, I., Abdayem, P., Planchard, D.
Publicado 2021

1719P Clinical characteristics and 28-day mortality among patients with solid cancers and COVID-19 in a tertiary hospital

por Tapia, J.C., Gavira, J., Riudavets, M., Ponce, O.J., Gich, I., Barnadas, A., Majem, M.
Publicado 2020